ISUPREL

This brand name is authorized in Estonia, France, United States

Active ingredients

The drug ISUPREL contains one active pharmaceutical ingredient (API):

1 Isoprenaline UNII DIA2A74855 - ISOPROTERENOL HYDROCHLORIDE

Isoprenaline is a potent non selective beta-adrenergic agonist with low affinity for alphaadrenergic receptors. Isoprenaline acts primarily on the heart and on smooth muscle of bronchi, skeletal muscle vasculature and the gastrointestinal tract. Read about Isoprenaline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ISUPREL Solution for injection	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01CA02	Isoprenaline	C Cardiovascular system → C01 Cardiac therapy → C01C Cardiac stimulants excl. cardiac glycosides → C01CA Adrenergic and dopaminergic agents
Discover more medicines within C01CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1126482, 1128642, 1173631, 1252864, 1285332, 1327418
Country: FR	Base de données publique des médicaments	Identifier(s): 68886179
Country: US	FDA, National Drug Code	Identifier(s): 0187-4330